Gabriela Schmajuk1, Chris Tonner2, Jinoos Yazdany3. 1. Veterans Affairs Medical Center-San Francisco, 4150 Clement St, Mailstop 111R, San Francisco, CA 94121; Division of Rheumatology, University of California-San Francisco, San Francisco, CA. Electronic address: gabriela.schmajuk@ucsf.edu. 2. Institute for Health Policy Studies, University of California, San Francisco, CA. 3. Division of Rheumatology, University of California-San Francisco, San Francisco, CA.
Abstract
OBJECTIVE: Despite looming rheumatologist shortages and a growing number of patients with arthritis and other rheumatic conditions, nationwide estimates of access to rheumatology care have never been reported. We aimed to measure travel times as a proxy to access to care and to determine the individual and area-level factors associated with long travel times to rheumatologists in the U.S. METHODS: We used Medicare Part B claims for the 2009 Medicare Chronic Condition Warehouse 5% rheumatoid arthritis/osteoarthritis cohort. Using Google Maps we estimated driving time from the center of a beneficiary's home ZIP code to the center of their rheumatologist's office ZIP code. We examined predictors of travel time ≥90 min in a series of generalized linear mixed models adjusting for rheumatologist supply, rurality, and individual patient characteristics including age, race, gender, and income. RESULTS: We included 41,693 Medicare beneficiaries with 1 or more visits to a rheumatologist in 2009. The median estimated beneficiary travel time to a rheumatologist was 22 min [interquartile range (IQR): 12-40 min]. Overall, 7% of beneficiaries traveled 90 min or longer to visit a rheumatologist. Even after adjusting for covariates, independent predictors of long travel times included living in areas with no or low supply of rheumatologists and living in the Mountain region of the U.S. CONCLUSIONS: A small but significant proportion of patients in the U.S. traveled very long distances to visit a rheumatologist, and most of these individuals resided in areas with no or low supplies of rheumatologists. These data suggest that addressing shortages in rheumatology care for patients in low-supply areas is a key target for improving access to rheumatologists. Published by Elsevier Inc.
OBJECTIVE: Despite looming rheumatologist shortages and a growing number of patients with arthritis and other rheumatic conditions, nationwide estimates of access to rheumatology care have never been reported. We aimed to measure travel times as a proxy to access to care and to determine the individual and area-level factors associated with long travel times to rheumatologists in the U.S. METHODS: We used Medicare Part B claims for the 2009 Medicare Chronic Condition Warehouse 5% rheumatoid arthritis/osteoarthritis cohort. Using Google Maps we estimated driving time from the center of a beneficiary's home ZIP code to the center of their rheumatologist's office ZIP code. We examined predictors of travel time ≥90 min in a series of generalized linear mixed models adjusting for rheumatologist supply, rurality, and individual patient characteristics including age, race, gender, and income. RESULTS: We included 41,693 Medicare beneficiaries with 1 or more visits to a rheumatologist in 2009. The median estimated beneficiary travel time to a rheumatologist was 22 min [interquartile range (IQR): 12-40 min]. Overall, 7% of beneficiaries traveled 90 min or longer to visit a rheumatologist. Even after adjusting for covariates, independent predictors of long travel times included living in areas with no or low supply of rheumatologists and living in the Mountain region of the U.S. CONCLUSIONS: A small but significant proportion of patients in the U.S. traveled very long distances to visit a rheumatologist, and most of these individuals resided in areas with no or low supplies of rheumatologists. These data suggest that addressing shortages in rheumatology care for patients in low-supply areas is a key target for improving access to rheumatologists. Published by Elsevier Inc.
Authors: Thomas A Arcury; Wilbert M Gesler; John S Preisser; Jill Sherman; John Spencer; Jamie Perin Journal: Health Serv Res Date: 2005-02 Impact factor: 3.402
Authors: Brenda Sirovich; Patricia M Gallagher; David E Wennberg; Elliott S Fisher Journal: Health Aff (Millwood) Date: 2008 May-Jun Impact factor: 6.301
Authors: Yunjie Song; Jonathan Skinner; Julie Bynum; Jason Sutherland; John E Wennberg; Elliott S Fisher Journal: N Engl J Med Date: 2010-05-12 Impact factor: 91.245
Authors: Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder Journal: Ann Intern Med Date: 2003-02-18 Impact factor: 25.391
Authors: Ashley Meilleur; S V Subramanian; Jesse J Plascak; James L Fisher; Electra D Paskett; Elizabeth B Lamont Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10 Impact factor: 4.254
Authors: Tomi F Akinyemiju; Amr S Soliman; Glenn Copeland; Mousumi Banerjee; Kendra Schwartz; Sofia D Merajver Journal: PLoS One Date: 2013-04-29 Impact factor: 3.240
Authors: Claire E H Barber; Diane Lacaille; Ruth Croxford; Cheryl Barnabe; Deborah A Marshall; Michal Abrahamowicz; Hui Xie; J Antonio Avina-Zubieta; John M Esdaile; Glen Hazlewood; Peter Faris; Steven Katz; Paul MacMullan; Dianne Mosher; Jessica Widdifield Journal: ACR Open Rheumatol Date: 2022-05-05
Authors: Yomei Shaw; Delphine S Courvoisier; Almut Scherer; Adrian Ciurea; Thomas Lehmann; Veronika K Jaeger; Ulrich A Walker; Axel Finckh Journal: RMD Open Date: 2021-04
Authors: Kate L Lapane; Catherine Dubé; Katarina Ferrucci; Sara Khan; Kristine A Kuhn; Esther Yi; Jonathan Kay; Shao-Hsien Liu Journal: BMC Fam Pract Date: 2021-12-20 Impact factor: 2.497